Panel Discussion: A Critical Review – What Will it Take to Progress Degraders Towards & Through the Clinic?

Time: 2:45 pm
day: Day Two


Targeted Protein Degradation continues to progress as a therapeutic with huge potential, and 2023 is shaping up to be a landmark year for the degradation community. With the emergence of over 88 newly disclosed TPD drugs in the first half of 2022, over 67 TPD drug updates and critical collaboration, this community continues to advance highly valuable degrader compounds closer to the clinic. This session will hear leaders of the community discuss breakthroughs, challenges and next steps advancing degraders through the clinic